Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Bitler

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Scientific Reports|November 10, 2025
Claudin-4 as a dual regulator of genome stability and immune evasion in high grade serous ovarian cancerBenjamin G Bitler, Julie Lang, Daniel Nunez-Avellaneda, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 14, 2022
Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid CarcinomaJennifer G Haag, Rebecca J Wolsky, Marisa R Moroney, et al.
Molecular and Cellular Biochemistry|July 12, 2019
Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cellsAmin A Ramzan, Benjamin G Bitler, Douglas Hicks, et al.
Developmental Cell|December 6, 2011
Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescenceZhigang Tu, Katherine M Aird, Benjamin G Bitler, et al.
Molecular Carcinogenesis|April 1, 2024
VDX-111, a novel small molecule, induces necroptosis to inhibit ovarian cancer progressionChristianne Persenaire, Beatrice Babbs, Tomomi M Yamamoto, et al.
BMC Research Notes|June 20, 2022
On clustering for cell-phenotyping in multiplex immunohistochemistry (mIHC) and multiplexed ion beam imaging (MIBI) dataSouvik Seal, Julia Wrobel, Amber M Johnson, et al.
Cancer Research Communications|June 13, 2024
Claudin-4 Modulates Autophagy via SLC1A5/LAT1 as a Mechanism to Regulate MicronucleiFabian R Villagomez, Julie Lang, Fredrick J Rosario, et al.
Oncogene|October 12, 2022
Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancerTzu-Ting Huang, Sandra Sczerba Burkett, Mayank Tandon, et al.
Molecular Cancer Research : MCR|May 22, 2019
Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian CancerErika S Dahl, Raquel Buj, Kelly E Leon, et al.
Cancer Immunology Research|June 21, 2022
KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian CancerHeng Liu, Jianhuang Lin, Wei Zhou, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Scientific Reports|November 10, 2025
Claudin-4 as a dual regulator of genome stability and immune evasion in high grade serous ovarian cancerBenjamin G Bitler, Julie Lang, Daniel Nunez-Avellaneda, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 14, 2022
Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid CarcinomaJennifer G Haag, Rebecca J Wolsky, Marisa R Moroney, et al.
Molecular and Cellular Biochemistry|July 12, 2019
Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cellsAmin A Ramzan, Benjamin G Bitler, Douglas Hicks, et al.
Developmental Cell|December 6, 2011
Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescenceZhigang Tu, Katherine M Aird, Benjamin G Bitler, et al.
Molecular Carcinogenesis|April 1, 2024
VDX-111, a novel small molecule, induces necroptosis to inhibit ovarian cancer progressionChristianne Persenaire, Beatrice Babbs, Tomomi M Yamamoto, et al.
BMC Research Notes|June 20, 2022
On clustering for cell-phenotyping in multiplex immunohistochemistry (mIHC) and multiplexed ion beam imaging (MIBI) dataSouvik Seal, Julia Wrobel, Amber M Johnson, et al.
Cancer Research Communications|June 13, 2024
Claudin-4 Modulates Autophagy via SLC1A5/LAT1 as a Mechanism to Regulate MicronucleiFabian R Villagomez, Julie Lang, Fredrick J Rosario, et al.
Oncogene|October 12, 2022
Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancerTzu-Ting Huang, Sandra Sczerba Burkett, Mayank Tandon, et al.
Molecular Cancer Research : MCR|May 22, 2019
Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian CancerErika S Dahl, Raquel Buj, Kelly E Leon, et al.
Cancer Immunology Research|June 21, 2022
KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian CancerHeng Liu, Jianhuang Lin, Wei Zhou, et al.
Pageof 12